SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 30 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $20,000 | -41.2% | 74,300 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $34,000 | -24.4% | 74,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $45,000 | -40.0% | 74,300 | -32.0% | 0.00% | 0.0% |
| Q1 2021 | $75,000 | +78.6% | 109,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $42,000 | -19.2% | 109,300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $52,000 | -7.1% | 109,300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $56,000 | – | 109,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 903,741 | $497,000 | 0.62% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,750,000 | 0.04% |
| WEDBUSH SECURITIES INC | 97,957 | $54,000 | 0.01% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $124,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $33,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $24,000 | 0.00% |
| UBS Group AG | 600 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 421 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 316 | $0 | 0.00% |